Company profile: Gemini Bio
1.1 - Company Overview
Company description
- Provider of FDA-registered biological products and chemical reagents for the global cell culture community, offering cell culture sera (fetal bovine and other human/animal), custom and specialized media and buffers, supplements and reagents (amino acids, antibiotics, antimycotics), high purity water including WFI-quality, and cGMP contract manufacturing/private-label process liquids.
Products and services
- Fetal Bovine Serum (FBS): A comprehensive line of cell culture-grade fetal bovine serum featuring various quality tiers and specialty products for cultivating diverse cell types across global cell culture workflows
- Custom cGMP Media and Buffers: cGMP-compliant custom manufacturing of media, buffers, and process liquids in batch sizes from 10 to 10,000 liters, tailored to specific bioprocess requirements
- Cell Culture Media: Specialized media portfolios including insect cell, neuronal, and T-Cell formulations, with custom manufacturing available to match protocol needs and support targeted cell growth and maintenance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gemini Bio
Biocoat
HQ: United States
Website
- Description: Provider of custom-engineered biomaterial coatings for medical devices, specializing in lubricious hydrophilic coatings that deliver lubricity, durability, and low particulate counts. Services include contract coating, custom polymer synthesis, and reagent fulfillment, with specialized hydrophilic solutions for neurovascular and cardiovascular devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocoat company profile →
Sarissa Biomedical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sarissa Biomedical company profile →
Trinean
HQ: Belgium
Website
- Description: Provider of micro-volume molecular spectroscopy solutions, combining best-in-class analytical software with a highly standardized read-out platform; commercializes UV/VIS spectrometers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trinean company profile →
PharmaFluidics
HQ: Belgium
Website
- Description: Provider of integrated milli- to nano-engineered solutions for mixing, separation and reaction processes, offering high-quality, tailor-made designs. Products include μPAC Neo silicon-based HPLC columns for high-resolution separations; EASY-Spray and Double nanoViper columns for nano/capillary LC-MS and robust proteomics; MAbPac RP for intact protein characterization; Accucore 150 Amide HILIC for hydrophilic biomolecules/glycans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaFluidics company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gemini Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gemini Bio
2.2 - Growth funds investing in similar companies to Gemini Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gemini Bio
4.2 - Public trading comparable groups for Gemini Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →